Data for ST000497
Metabolite structure | All data | F1 | F2 | F3 | F4 | F5 | F6 | F7 |
---|---|---|---|---|---|---|---|---|
13-HODE + 9-HODE | 0.96 | 2.00 | 1.08 | 1.49 | 0.81 | 6.28 | 1.44 | |
1-linoleoylglycerol (1-monolinolein) | 0.82 | 1.15 | 0.62 | 0.69 | 0.89 | 2.72 | 0.83 | |
1-oleoylglycerophosphoglycerol* | 1.52 | 1.22 | 0.95 | 0.64 | 0.40 | 1.54 | 0.43 | |
1-palmitoylglycerophosphate | 1.33 | 1.55 | 1.34 | 1.13 | 0.68 | 8.63 | 1.74 | |
1-palmitoylglycerophosphoethanolamine | 1.22 | 1.87 | 0.93 | 1.38 | 0.55 | 4.06 | 1.75 | |
1-palmitoylglycerophosphoglycerol* | 1.53 | 2.12 | 0.95 | 1.04 | 0.35 | 2.91 | 1.10 | |
1-palmitoylglycerophosphoinositol* | 0.93 | 1.41 | 1.24 | 0.89 | 0.60 | 14.44 | 1.83 | |
2-hydroxydecanoate | 1.16 | 0.81 | 0.79 | 1.65 | 1.30 | 0.72 | 0.41 | |
2-hydroxypalmitate | 1.97 | 2.01 | 1.03 | 1.07 | 0.63 | 7.72 | 1.06 | |
2-isopropylmalate | 1.01 | 2.56 | 0.50 | 1.36 | 0.60 | 1.60 | 0.41 | |
2-myristoylglycerol (2-monomyristin) | 1.12 | 1.27 | 1.04 | 0.76 | 0.32 | 1.25 | 1.86 | |
3-butenylglucosinolate | 0.58 | 0.55 | 0.55 | 0.77 | 0.55 | 0.55 | 0.55 | |
5-oxoproline | 0.83 | 1.72 | 0.76 | 1.85 | 0.92 | 2.85 | 2.87 | |
9,10-epoxystearate | 1.06 | 1.79 | 0.96 | 2.66 | 1.00 | 4.07 | 0.53 | |
anthraniloyl-O-glucose | 0.83 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | |
azelate (nonanedioate) | 1.23 | 1.33 | 1.18 | 1.90 | 1.46 | 1.66 | 0.42 | |
coumaroylquinate | 0.74 | 1.26 | 2.84 | 0.95 | 2.43 | 3.69 | 1.48 | |
cytidine | 0.90 | 1.26 | 1.05 | 1.25 | 0.88 | 1.20 | 1.32 | |
histidine | 0.79 | 1.36 | 1.35 | 4.73 | 1.53 | 5.76 | 6.36 | |
linoleate (18:2n6) | 1.57 | 2.14 | 0.82 | 0.68 | 0.65 | 3.03 | 0.81 | |
linolenate [alpha or gamma; (18:3n3 or 6)] | 1.95 | 2.09 | 0.97 | 0.57 | 0.69 | 3.22 | 0.53 | |
malonate (propanedioate) | 0.89 | 1.19 | 1.24 | 1.07 | 0.94 | 1.29 | 1.00 | |
phosphoethanolamine | 0.72 | 0.35 | 0.92 | 0.98 | 1.16 | 0.51 | 1.02 | |
pyridoxate | 0.89 | 1.28 | 1.01 | 1.23 | 1.39 | 1.01 | 0.91 | |
salidroside | 0.98 | 1.00 | 1.19 | 1.01 | 1.32 | 1.10 | 0.70 | |
sebacate (decanedioate) | 0.89 | 1.10 | 0.73 | 1.46 | 1.12 | 1.33 | 0.41 | |
sucrose | 1.66 | 5.16 | 0.30 | 1.40 | 0.58 | 1.71 | 0.60 | |
undecanedioate | 0.99 | 0.91 | 0.87 | 1.12 | 1.25 | 1.39 | 0.35 | |
uridine | 0.83 | 1.31 | 0.87 | 1.31 | 0.88 | 1.29 | 1.37 | |
valylleucine | 1.68 | 1.39 | 0.88 | 0.86 | 0.68 | 0.86 | 0.86 |
Factors:
F1 | Treatment:control | Sample_description:- |
F2 | Treatment:Infected | Sample_description:complete green recovery |
F3 | Treatment:Infected | Sample_description:mosaic |
F4 | Treatment:Infected | Sample_description:patial green recovery |
F5 | Treatment:Infected | Sample_description:secondary mosaic |
F6 | Treatment:Infected | Sample_description:vein clearing |
F7 | Treatment:Infected | Sample_description:white chlorosis |